IO Biotech, Inc.
IOBT
$1.72
$0.010.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.98% | 7.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.59% | -16.18% | |||
| Operating Income | -2.59% | 16.18% | |||
| Income Before Tax | -17.17% | 27.88% | |||
| Income Tax Expenses | -19.18% | -67.19% | |||
| Earnings from Continuing Operations | -16.93% | 28.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.93% | 28.44% | |||
| EBIT | -2.59% | 16.18% | |||
| EBITDA | -2.59% | 16.21% | |||
| EPS Basic | -16.93% | 28.45% | |||
| Normalized Basic EPS | -17.18% | 27.88% | |||
| EPS Diluted | -16.93% | 28.45% | |||
| Normalized Diluted EPS | -17.18% | 27.88% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||